Receptors, Granulocyte-Macrophage Colony-Stimulating Factor
"Receptors, Granulocyte-Macrophage Colony-Stimulating Factor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Receptors that bind and internalize the granulocyte-macrophage stimulating factor. Their MW is believed to be 84 kD. The most mature myelomonocytic cells, specifically human neutrophils, macrophages, and eosinophils, express the highest number of affinity receptors for this growth factor.
Descriptor ID |
D016187
|
MeSH Number(s) |
D12.776.543.750.705.852.150.310 D12.776.543.750.750.400.200.420
|
Concept/Terms |
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor- Receptors, Granulocyte-Macrophage Colony-Stimulating Factor
- Receptors, Granulocyte Macrophage Colony Stimulating Factor
- Receptors, GM-CSF
- Receptors, GM CSF
- GM-CSF Receptors
- GM CSF Receptors
- CD116 Antigens
- CD116 Antigen
- Antigen, CD116
- Antigens, CD116
- GM-CSF Receptor
- GM CSF Receptor
- Receptor, GM-CSF
- Receptor, Granulocyte-Macrophage Colony-Stimulating Factor
- Receptor, Granulocyte Macrophage Colony Stimulating Factor
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Granulocyte-Macrophage Colony-Stimulating Factor".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, Immunologic [D12.776.543.750.705]
- Receptors, Cytokine [D12.776.543.750.705.852]
- Receptors, Colony-Stimulating Factor [D12.776.543.750.705.852.150]
- Receptors, Granulocyte-Macrophage Colony-Stimulating Factor [D12.776.543.750.705.852.150.310]
- Receptors, Peptide [D12.776.543.750.750]
- Receptors, Growth Factor [D12.776.543.750.750.400]
- Receptors, Colony-Stimulating Factor [D12.776.543.750.750.400.200]
- Receptors, Granulocyte-Macrophage Colony-Stimulating Factor [D12.776.543.750.750.400.200.420]
Below are MeSH descriptors whose meaning is more specific than "Receptors, Granulocyte-Macrophage Colony-Stimulating Factor".
This graph shows the total number of publications written about "Receptors, Granulocyte-Macrophage Colony-Stimulating Factor" by people in this website by year, and whether "Receptors, Granulocyte-Macrophage Colony-Stimulating Factor" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2007 | 0 | 1 | 1 |
2017 | 2 | 0 | 2 |
2018 | 1 | 1 | 2 |
2019 | 0 | 2 | 2 |
2020 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptors, Granulocyte-Macrophage Colony-Stimulating Factor" by people in Profiles.
-
Microglia depletion exacerbates demyelination and impairs remyelination in a neurotropic coronavirus infection. Proc Natl Acad Sci U S A. 2020 09 29; 117(39):24464-24474.
-
Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies. Front Immunol. 2020; 11:1625.
-
Mavrilimumab: a unique insight and update on the current status in the treatment of rheumatoid arthritis. Expert Opin Investig Drugs. 2019 Jul; 28(7):573-581.
-
Chronic inflammation, cognitive impairment, and distal brain region alteration following intracerebral hemorrhage. FASEB J. 2019 08; 33(8):9616-9626.
-
Mavrilimumab, a Fully Human Granulocyte-Macrophage Colony-Stimulating Factor Receptor a Monoclonal Antibody: Long-Term Safety and Efficacy in Patients With Rheumatoid Arthritis. Arthritis Rheumatol. 2018 05; 70(5):679-689.
-
Microglia are required for protection against lethal coronavirus encephalitis in mice. J Clin Invest. 2018 03 01; 128(3):931-943.
-
Effects of polymorphisms identified in genome-wide association studies of never-smoking females on the prognosis of non-small cell lung cancer. Cancer Genet. 2017 04; 212-213:8-12.
-
A randomised phase IIb study of mavrilimumab, a novel GM-CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis. Ann Rheum Dis. 2017 Jun; 76(6):1020-1030.
-
Agents under investigation for the treatment and prevention of neutropenia. Expert Opin Investig Drugs. 2007 Nov; 16(11):1831-40.
-
Expression and modulation of IL-3 and GM-CSF receptors in human growth factor dependent leukaemic cells. Br J Haematol. 1990 Oct; 76(2):203-9.